美股周五早盘，基因组分析科学仪器公司Bionano Genomics（BNGO）将其2025年光学基因组图谱（OGM）设备安装目标上调至25台，同时耗材与软件收入增长16%。该公司公布第二季度营收达670万美元，目前正重点支持其光学基因组图谱技术的常规用户。

　　Bionano正通过加强软件产品组合来推动业务增长。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：张俊 SF065

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.